The company floated in Australia rather than the US as its EndoBarrier product for type II diabetes has regulatory approval in the country but has yet to be passed by America's.
US-based medical device maker company GI Dynamics has raised $80m in a flotation on the Australian stock exchange and private placement of stock.
The company floated in Australia rather than the US as its EndoBarrier product (pictured) for type II diabetes has regulatory approval in the country but has yet to be passed by America’s.
The lead manager of the initial public offering was Inteq, while Bell Potter Securities was broker.
GI said its investors included healthcare providers Johnson…
